Profile data is unavailable for this security.
About the company
Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.
- Revenue in USD (TTM)0.00
- Net income in USD5.54m
- Incorporated2020
- Employees--
- LocationIbere Pharmaceuticals2005 Market Street, Suite 2030PHILADELPHIA 19103United StatesUSA
- Phone+1 (267) 765-3222
- Websitehttps://www.iberepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deep Medicine Acquisition Corp | 0.00 | -414.04k | 165.98m | -- | -- | 1.34 | -- | -- | -0.0253 | -0.0253 | 0.00 | 7.55 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -99.01 | 0.00 | -- | -- | -- | -597.05 | -- | -- | -- |
| Special Opportunities Fund Inc. | -100.00bn | -100.00bn | 167.18m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Voya Infrstrcture Industrls and Mtrls Fd | -100.00bn | -100.00bn | 168.55m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| AG Mortgage Investment Trust Inc | 117.14m | -34.83m | 169.44m | 0.00 | -- | 0.6559 | -- | 1.45 | -0.8226 | -0.8226 | 5.67 | 21.28 | 0.0387 | -- | 2.12 | -- | -0.4265 | -1.02 | -0.656 | -3.63 | 41.50 | 46.95 | -11.01 | -27.25 | -- | 1.11 | 0.8756 | -- | -5.18 | -10.49 | 119.90 | 11.33 | -- | -28.70 |
| Ibere Pharmaceuticals | 0.00 | 5.54m | 169.91m | -- | 30.67 | 1.30 | 30.67 | -- | 0.3212 | 0.3212 | 0.00 | 7.58 | 0.00 | -- | -- | -- | 3.99 | -- | 4.00 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27,213.71 | -- | -- | -- |
| Grayscale Ethereum Classic Trust (Etc) | 0.00 | 401.30m | 170.02m | -- | 0.4237 | 0.2985 | -- | -- | 28.68 | 28.68 | 0.00 | 40.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 4,900.69 | -- | -- | -- |
| abrdn Standard Globl Infrstrctr Incm Fnd | 18.07m | 22.41m | 170.72m | -- | 7.62 | 0.8322 | -- | 9.45 | 2.53 | 2.53 | 2.04 | 23.17 | 0.0903 | -- | -- | -- | 11.20 | -- | 11.22 | -- | 81.94 | -- | 124.00 | -- | -- | -- | 0.00 | -- | 1,859.32 | -- | 821.36 | -- | -- | -- |
| Western Asset Global High Income Fnd Inc | -100.00bn | -100.00bn | 171.82m | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| JATT Acquisition Corp | 0.00 | 7.03m | 172.50m | -- | 24.54 | 1.32 | 29.07 | -- | 0.4075 | 0.4075 | 0.00 | 7.56 | 0.00 | -- | -- | -- | 10.02 | -- | 10.05 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| AP Acquisition Corp | -100.00bn | -100.00bn | 172.68m | -- | -- | 1.26 | -- | -- | -- | -- | -- | 8.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0002 | -- | -- | -- | -- | -- | -- | -- |
| Nuveen Intermediate Duration Qlty Mun FD | 8.29m | 8.51m | 173.17m | -- | 20.34 | 0.8874 | -- | 20.89 | 0.65 | 0.65 | 0.6329 | 14.90 | 0.0331 | -- | 1.50 | -- | 3.40 | 3.04 | 3.42 | 3.09 | 76.15 | 71.31 | 102.71 | 88.57 | -- | -- | 0.2198 | 76.97 | 5.59 | -1.40 | 145.00 | -2.13 | -- | -4.53 |
| Murphy Canyon Acquisition Corp | -100.00bn | -100.00bn | 173.20m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Clough Global Equity Fund | -100.00bn | -100.00bn | 173.72m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| BNY Mellon High Yield Strategies Fund | -100.00bn | -100.00bn | 173.84m | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Lightjump Acquisition Corp | 0.00 | -921.79k | 174.57m | -- | -- | 1.29 | -- | -- | -0.0531 | -0.0531 | 0.00 | 7.78 | 0.00 | -- | -- | -- | -0.6645 | -- | -0.671 | -- | -- | -- | -- | -- | -- | -- | 0.0056 | -- | -- | -- | -579.78 | -- | -- | -- |
Data as of Aug 09 2022. Currency figures normalised to Ibere Pharmaceuticals's reporting currency: US Dollar USD
52.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Advisory LLCas of 30 Jun 2022 | 2.73m | 19.77% |
| Citadel Advisors LLCas of 31 Mar 2022 | 777.70k | 5.64% |
| Hudson Bay Capital Management LPas of 31 Mar 2022 | 617.00k | 4.47% |
| Marshall Wace LLPas of 31 Mar 2022 | 532.19k | 3.86% |
| Polar Asset Management Partners, Inc.as of 31 Mar 2022 | 500.00k | 3.62% |
| Linden Advisors LPas of 31 Mar 2022 | 450.00k | 3.26% |
| Millennium Management LLCas of 31 Mar 2022 | 441.88k | 3.20% |
| Sculptor Capital LPas of 31 Mar 2022 | 425.00k | 3.08% |
| Omni Partners LLPas of 31 Mar 2022 | 422.03k | 3.06% |
| Koch Industries, Inc. (Investment Management)as of 31 Mar 2022 | 400.00k | 2.90% |
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
